A detailed history of Israel Englander (Millennium Management LLC) transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Millennium Management LLC holds 20,030 shares of VRCA stock, worth $159,238. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,030
Holding current value
$159,238
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.95 - $7.95 $159,238 - $159,238
20,030 New
20,030 $159,000
Q2 2023

Aug 14, 2023

BUY
$5.32 - $6.79 $438,378 - $559,509
82,402 Added 46.24%
260,614 $1.5 Million
Q1 2023

May 15, 2023

SELL
$2.88 - $8.51 $78,433 - $231,761
-27,234 Reduced 13.26%
178,212 $1.16 Million
Q4 2022

Feb 14, 2023

BUY
$2.09 - $3.39 $274,567 - $445,351
131,372 Added 177.35%
205,446 $565,000
Q3 2022

Nov 14, 2022

SELL
$2.17 - $4.3 $129,462 - $256,538
-59,660 Reduced 44.61%
74,074 $216,000
Q2 2022

Aug 15, 2022

BUY
$1.81 - $8.93 $65,208 - $321,721
36,027 Added 36.87%
133,734 $257,000
Q1 2022

May 16, 2022

BUY
$7.59 - $9.49 $26,466 - $33,091
3,487 Added 3.7%
97,707 $792,000
Q4 2021

Feb 14, 2022

BUY
$9.1 - $13.36 $706,069 - $1.04 Million
77,590 Added 466.57%
94,220 $863,000
Q3 2021

Nov 15, 2021

SELL
$9.55 - $13.96 $2.89 Million - $4.23 Million
-302,922 Reduced 94.8%
16,630 $208,000
Q2 2021

Aug 16, 2021

BUY
$9.77 - $15.33 $2.8 Million - $4.39 Million
286,134 Added 856.23%
319,552 $3.61 Million
Q1 2021

May 17, 2021

SELL
$10.51 - $17.46 $3.17 Million - $5.27 Million
-301,900 Reduced 90.03%
33,418 $506,000
Q4 2020

Feb 16, 2021

SELL
$7.41 - $12.63 $204,893 - $349,232
-27,651 Reduced 7.62%
335,318 $3.86 Million
Q3 2020

Nov 16, 2020

BUY
$6.16 - $10.3 $2.24 Million - $3.74 Million
362,969 New
362,969 $2.81 Million
Q3 2018

Nov 14, 2018

SELL
$13.94 - $19.88 $358,941 - $511,890
-25,749 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$17.5 - $20.34 $450,607 - $523,734
25,749 New
25,749 $508,000

Others Institutions Holding VRCA

About Verrica Pharmaceuticals Inc.


  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.